{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T04:29:17Z","timestamp":1793939357007,"version":"4.8.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"DOI":"10.1007\/s10822-026-00847-w","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T05:54:01Z","timestamp":1780898041000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Diphenylpiperazine attached to different triazole acetamide derivatives as a potent \u03b1-glucosidase inhibitor, new insight into the in silico study of an uncompetitive inhibitor"],"prefix":"10.1007","volume":"40","author":[{"given":"Mehran","family":"Ghasemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Sepehri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Biglar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Mahdavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cambyz","family":"Irajie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bagher","family":"Larijani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Al-Harrasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Iraji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"847_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115734","volume":"168","author":"SA Antar","year":"2023","unstructured":"Antar SA, Ashour NA, Sharaky M, Khattab M, Ashour NA, Zaid RT, Roh EJ, Elkamhawy A, Al-Karmalawy AA (2023) Diabetes mellitus: classification, mediators, and complications; a gate to identify potential targets for the development of new effective treatments. Biomed Pharmacother 168:115734","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"847_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-14896-2","volume":"12","author":"M Askarzadeh","year":"2022","unstructured":"Askarzadeh M, Azizian H, Adib M, Mohammadi-Khanaposhtani M, Mojtabavi S, Faramarzi MA, Sajjadi-Jazi SM, Larijani B, Hamedifar H, Mahdavi M (2022) Design, synthesis, in vitro \u03b1-glucosidase inhibition, docking, and molecular dynamics of new phthalimide-benzenesulfonamide hybrids for targeting type 2 diabetes. Sci Rep 12(1):10569","journal-title":"Sci Rep"},{"key":"847_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107106","volume":"144","author":"A Azmi","year":"2024","unstructured":"Azmi A, Noori M, Khalili Ghomi M, Nazari Montazer M, Iraji A, Dastyafteh N, Oliyaei N, Khoramjouy M, Rezaei Z, Javanshir S, Mojtabavi S, Faramarzi MA, Asadi M, Faizi M, Mahdavi M (2024) Alpha-glucosidase inhibitory and hypoglycemic effects of imidazole-bearing thioquinoline derivatives with different substituents: in silico, in vitro, and in vivo evaluations. Bioorg Chem 144:107106","journal-title":"Bioorg Chem"},{"key":"847_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2023.125052","volume":"266","author":"X Chen","year":"2024","unstructured":"Chen X, Chen C, Tian X, He L, Zuo E, Liu P, Xue Y, Yang J, Chen C, Lv X (2024) DBAN: an improved dual branch attention network combined with serum Raman spectroscopy for diagnosis of diabetic kidney disease. Talanta 266:125052","journal-title":"Talanta"},{"key":"847_CR5","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ejmech.2019.04.025","volume":"176","author":"M Dhameja","year":"2019","unstructured":"Dhameja M, Gupta P (2019) Synthetic heterocyclic candidates as promising \u03b1-glucosidase inhibitors: an overview. Eur J Med Chem 176:343\u2013377","journal-title":"Eur J Med Chem"},{"key":"847_CR6","unstructured":"Feingold KR (2022) Oral and injectable (non-insulin) pharmacological agents for the treatment of type 2 diabetes. Endotext [Internet]"},{"issue":"1","key":"847_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-35140-5","volume":"13","author":"R Forozan","year":"2023","unstructured":"Forozan R, Ghomi MK, Iraji A, Montazer MN, Noori M, Dastyafteh N, Mojtabavi S, Faramarzi MA, Sadat-Ebrahimi SE, Larijani B, Javanshir S, Mahdavi M (2023) Synthesis, in vitro inhibitor screening, structure\u2013activity relationship, and molecular dynamic simulation studies of novel thioquinoline derivatives as potent \u03b1-glucosidase inhibitors. Sci Rep 13(1):7819","journal-title":"Sci Rep"},{"issue":"21","key":"847_CR8","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA, Sanschagrin PC, Mainz DT (2006) Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein\u2013ligand complexes. J Med Chem 49(21):6177\u20136196","journal-title":"J Med Chem"},{"issue":"5","key":"847_CR9","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.55730\/1300-0527.3453","volume":"46","author":"U Ghani","year":"2022","unstructured":"Ghani U, Ashraf S, Haq ZU, Kaplancikli ZA, Demirci F, \u00d6zkay Y, Afzal S (2022) The 4-(dimethylaminoalkyl) piperazine inhibitors of \u03b1-glucosidase: allosteric enzyme inhibition and identification of interacting chemical groups. Turk J Chem 46(5):1484\u20131492","journal-title":"Turk J Chem"},{"key":"847_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107908","volume":"153","author":"M Ghasemi","year":"2024","unstructured":"Ghasemi M, Iraji A, Dehghan M, Nosood YL, Irajie C, Khouzani NB, Mojtabavi S, Faramarzi MA, Mahdavi M, Al-Harrasi A (2024) Rational design of new quinoline-benzimidazole scaffold bearing piperazine acetamide derivatives as antidiabetic agents. Bioorg Chem 153:107908","journal-title":"Bioorg Chem"},{"issue":"1","key":"847_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-83917-z","volume":"15","author":"M Ghasemi","year":"2025","unstructured":"Ghasemi M, Mahdavi M, Dehghan M, Eftekharian M, Mojtabavi S, Faramarzi MA, Iraji A, Al-Harrasi A (2025) Substituted piperazine conjugated to quinoline-thiosemicarbazide as potent \u03b1-glucosidase inhibitors to target hyperglycemia. Sci Rep 15(1):1871","journal-title":"Sci Rep"},{"issue":"6-7","key":"847_CR12","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s10822-010-9349-1","volume":"24","author":"JR Greenwood","year":"2010","unstructured":"Greenwood JR, Calkins D, Sullivan AP, Shelley JC (2010) Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution. J Comput Aided Mol Des 24(6\u20137):591\u2013604","journal-title":"J Comput Aided Mol Des"},{"key":"847_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.108060","volume":"154","author":"M Hatamfayazi","year":"2024","unstructured":"Hatamfayazi M, Mahdavi M, Dehaghi SM, Khoshneviszadeh M, Iraji A (2024) Synthesis and biological assessment of benzimidazole-acrylonitrile-1, 2, 3-triazole derivatives as \u03b1-glucosidase inhibitors. Bioorg Chem 154:108060","journal-title":"Bioorg Chem"},{"key":"847_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.108060","volume":"154","author":"M Hatamfayazi","year":"2025","unstructured":"Hatamfayazi M, Mahdavi M, Moradi Dehaghi S, Khoshneviszadeh M, Iraji A (2025) Synthesis and biological assessment of benzimidazole-acrylonitrile-1,2,3-triazole derivatives as \u03b1-glucosidase inhibitors. Bioorg Chem 154:108060","journal-title":"Bioorg Chem"},{"issue":"3","key":"847_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.2004","volume":"7","author":"MJ Hossain","year":"2024","unstructured":"Hossain MJ, Al-Mamun M, Islam MR (2024) Diabetes mellitus, the fastest growing global public health concern: early detection should be focused. Health Sci Rep 7(3):e2004","journal-title":"Health Sci Rep"},{"issue":"2","key":"847_CR16","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/prot.10613","volume":"55","author":"MP Jacobson","year":"2004","unstructured":"Jacobson MP, Pincus DL, Rapp CS, Day TJ, Honig B, Shaw DE, Friesner RA (2004) A hierarchical approach to all-atom protein loop prediction. Proteins 55(2):351\u2013367","journal-title":"Proteins"},{"issue":"5","key":"847_CR17","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1007\/s11030-021-10337-w","volume":"26","author":"M Karami","year":"2022","unstructured":"Karami M, Hasaninejad A (2022) One-pot multi-component synthesis of novel chromeno[4,3-b]pyrrol-3-yl derivatives as alpha-glucosidase inhibitors. Mol Divers 26(5):2393\u20132405","journal-title":"Mol Divers"},{"issue":"5","key":"847_CR18","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1007\/s11030-021-10337-w","volume":"26","author":"M Karami","year":"2022","unstructured":"Karami M, Hasaninejad A, Mahdavi H, Iraji A, Mojtabavi S, Faramarzi MA, Mahdavi M (2022) One-pot multi-component synthesis of novel chromeno[4,3-b]pyrrol-3-yl derivatives as alpha-glucosidase inhibitors. Mol Divers 26(5):2393\u20132405","journal-title":"Mol Divers"},{"key":"847_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116332","volume":"269","author":"M Khalili Ghomi","year":"2024","unstructured":"Khalili Ghomi M, Noori M, Mirahmad M, Iraji A, Sadr AS, Dastyafteh N, Asili P, Gholami M, Javanshir S, Lotfi M, Mojtabavi S, Faramarzi MA, Asadi M, Nasli-Esfahani E, Palimi M, Larijani B, Meshkatalsadat MH, Mahdavi M (2024) Evaluation of novel 2-(quinoline-2-ylthio)acetamide derivatives linked to diphenyl-imidazole as \u03b1-glucosidase inhibitors: insights from in silico, in vitro, and in vivo studies on their anti-diabetic properties. Eur J Med Chem 269:116332","journal-title":"Eur J Med Chem"},{"issue":"4","key":"847_CR20","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.bbrc.2019.01.023","volume":"509","author":"A-N Li","year":"2019","unstructured":"Li A-N, Chen J-J, Li Q-Q, Zeng G-Y, Chen Q-Y, Chen J-L, Liao Z-M, Jin P, Wang K-S, Yang Z-C (2019) Alpha-glucosidase inhibitor 1-deoxynojirimycin promotes beige remodeling of 3T3-L1 preadipocytes via activating AMPK. Biochem Biophys Res Commun 509(4):1001\u20131007","journal-title":"Biochem Biophys Res Commun"},{"issue":"20","key":"847_CR21","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.2174\/0113816128302667240422110226","volume":"30","author":"J Liang","year":"2024","unstructured":"Liang J, He Y, Huang C, Ji F, Zhou X, Yin Y (2024) The regulation of selenoproteins in diabetes: a new way to treat diabetes. Curr Pharm Des 30(20):1541\u20131547","journal-title":"Curr Pharm Des"},{"issue":"4","key":"847_CR22","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00011-019-01220-4","volume":"68","author":"W Mi","year":"2019","unstructured":"Mi W, Xia Y, Bian Y (2019) The influence of ICAM1 rs5498 on diabetes mellitus risk: evidence from a meta-analysis. Inflamm Res 68(4):275\u2013284","journal-title":"Inflamm Res"},{"issue":"3","key":"847_CR23","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1039\/D2MD00297C","volume":"14","author":"S Moghadam Farid","year":"2023","unstructured":"Moghadam Farid S, Iraji A, Mojtabavi S, Ghasemi M, Faramarzi MA, Mahdavi M, Barazandeh Tehrani M, Akbarzadeh T, Saeedi M (2023) Quinazolinone-1,2,3-triazole-acetamide conjugates as potent \u03b1-glucosidase inhibitors: synthesis, enzyme inhibition, kinetic analysis, and molecular docking study. RSC Med Chem 14(3):520\u2013533","journal-title":"RSC Med Chem"},{"issue":"1","key":"847_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-31080-2","volume":"13","author":"S Moghadam Farid","year":"2023","unstructured":"Moghadam Farid S, Noori M, Nazari Montazer M, Khalili Ghomi M, Mollazadeh M, Dastyafteh N, Irajie C, Zomorodian K, Mirfazli SS, Mojtabavi S, Faramarzi MA, Larijani B, Iraji A, Mahdavi M (2023) Synthesis and structure\u2013activity relationship studies of benzimidazole-thioquinoline derivatives as \u03b1-glucosidase inhibitors. Sci Rep 13(1):4392","journal-title":"Sci Rep"},{"issue":"1","key":"847_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-18455-7","volume":"12","author":"M Noori","year":"2022","unstructured":"Noori M, Davoodi A, Iraji A, Dastyafteh N, Khalili M, Asadi M, Mohammadi Khanaposhtani M, Mojtabavi S, Dianatpour M, Faramarzi MA, Larijani B, Amanlou M, Mahdavi M (2022) Design, synthesis, and in silico studies of quinoline-based-benzo[d]imidazole bearing different acetamide derivatives as potent \u03b1-glucosidase inhibitors. Sci Rep 12(1):14019","journal-title":"Sci Rep"},{"issue":"2","key":"847_CR26","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1039\/D5RA08761A","volume":"16","author":"F Noreen","year":"2026","unstructured":"Noreen F, Zaki MEA, Sadeghian N, Tokali FS, Taslimi P, Alharthy RD, \u015eenol H, Zhao X, \u00c7ak\u0131r F, Gomha SM, Shafiq Z (2026) Rational design of phenyl 2,4,5-trichlorobenzenesulfonate based thiosemicarbazones as \u03b1-glucosidase and \u03b1-amylase inhibitors: integrating enzymatic evaluation and molecular modeling. RSC Adv 16(2):1662\u20131681","journal-title":"RSC Adv"},{"key":"847_CR27","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.bioorg.2017.12.019","volume":"76","author":"M \u00d6zil","year":"2018","unstructured":"\u00d6zil M, Parlak C, Balta\u015f N (2018) A simple and efficient synthesis of benzimidazoles containing piperazine or morpholine skeleton at C-6 position as glucosidase inhibitors with antioxidant activity. Bioorg Chem 76:468\u2013477","journal-title":"Bioorg Chem"},{"issue":"18","key":"847_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e37467","volume":"10","author":"G Pan","year":"2024","unstructured":"Pan G, Lu Y, Wei Z, Li Y, Li L, Pan X (2024) A review on the in vitro and in vivo screening of \u03b1-glucosidase inhibitors. Heliyon 10(18):e37467","journal-title":"Heliyon"},{"issue":"1","key":"847_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-36046-y","volume":"13","author":"M Saeedi","year":"2023","unstructured":"Saeedi M, Hariri R, Iraji A, Ahmadi A, Mojtabavi S, Golshani S, Faramarzi MA, Akbarzadeh T (2023) Novel N\u2032-substituted benzylidene benzohydrazides linked to 1,2,3-triazoles: potent \u03b1-glucosidase inhibitors. Sci Rep 13(1):8960","journal-title":"Sci Rep"},{"issue":"3","key":"847_CR30","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"GM Sastry","year":"2013","unstructured":"Sastry GM, Adzhigirey M, Day T, Annabhimoju R, Sherman W (2013) Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des 27(3):221\u2013234","journal-title":"J Comput Aided Mol Des"},{"issue":"1","key":"847_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-32889-7","volume":"13","author":"N Shayegan","year":"2023","unstructured":"Shayegan N, Haghipour S, Tanideh N, Moazzam A, Mojtabavi S, Faramarzi MA, Irajie C, Parizad S, Ansari S, Larijani B, Hosseini S, Iraji A, Mahdavi M (2023) Synthesis, in vitro \u03b1-glucosidase inhibitory activities, and molecular dynamic simulations of novel 4-hydroxyquinolinone-hydrazones as potential antidiabetic agents. Sci Rep 13(1):6304","journal-title":"Sci Rep"},{"key":"847_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2022.133650","volume":"1268","author":"N Shayegan","year":"2022","unstructured":"Shayegan N, Iraji A, Bakhshi N, Moazzam A, Faramarzi MA, Mojtabavi S, Pour SMM, Tehrani MB, Larijani B, Rezaei Z, Yousefi P, Khoshneviszadeh M, Mahdavi M (2022) Design, synthesis, and in silico studies of benzimidazole bearing phenoxyacetamide derivatives as \u03b1-glucosidase and \u03b1-amylase inhibitors. J Mol Struct 1268:133650","journal-title":"J Mol Struct"},{"issue":"48","key":"847_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202204019","volume":"7","author":"F Sinan Tokal\u0131","year":"2022","unstructured":"Sinan Tokal\u0131 F (2022) Novel benzoic acid derivatives bearing quinazolin\u20104 (3H)\u2010one ring: synthesis, characterization, and inhibition effects on \u03b1\u2010glucosidase and \u03b1\u2010amylase. ChemistrySelect 7(48):e202204019","journal-title":"ChemistrySelect"},{"issue":"19","key":"847_CR34","doi-asserted-by":"publisher","first-page":"12011","DOI":"10.1039\/D2RA00067A","volume":"12","author":"M Sohrabi","year":"2022","unstructured":"Sohrabi M, Binaeizadeh MR, Iraji A, Larijani B, Saeedi M, Mahdavi M (2022) A review on \u03b1-glucosidase inhibitory activity of first row transition metal complexes: a futuristic strategy for treatment of type 2 diabetes. RSC Adv 12(19):12011\u201312052","journal-title":"RSC Adv"},{"key":"847_CR35","doi-asserted-by":"publisher","first-page":"1243834","DOI":"10.3389\/fimmu.2023.1243834","volume":"14","author":"M Su","year":"2023","unstructured":"Su M, Tang T, Tang W, Long Y, Wang L, Liu M (2023) Astragalus improves intestinal barrier function and immunity by acting on intestinal microbiota to treat T2DM: a research review. Front Immunol 14:1243834","journal-title":"Front Immunol"},{"key":"847_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2025.118264","volume":"128","author":"FS Tokal\u0131","year":"2025","unstructured":"Tokal\u0131 FS, Demir Y, Ate\u015fo\u011flu \u015e, Tokal\u0131 P, \u015eenol H (2025) Development of phenolic Mannich bases as \u03b1-glucosidase and aldose reductase inhibitors: In vitro and in silico approaches for managing diabetes mellitus and its complications. Bioorg Med Chem 128:118264","journal-title":"Bioorg Med Chem"},{"issue":"8","key":"847_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.70412","volume":"39","author":"FS Tokal\u0131","year":"2025","unstructured":"Tokal\u0131 FS, Demir Y, Tokal\u0131 P, Ate\u015fo\u011flu \u015e, \u015eenol H (2025) New quinazolin-4 (3H)-One\u2013Thiazolidine-2,4-dione hybrids as dual inhibitors of \u03b1-glycosidase and aldose reductase: the synthetic, in vitro, and in silico approaches. J Biochem Mol Toxicol 39(8):e70412","journal-title":"J Biochem Mol Toxicol"},{"issue":"2","key":"847_CR38","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s13738-021-02331-8","volume":"19","author":"FS Tokal\u0131","year":"2022","unstructured":"Tokal\u0131 FS, Taslimi P, Demircio\u011flu \u0130H, \u015eendil K, Tuzun B, G\u00fcl\u00e7in \u0130 (2022) Novel phenolic Mannich base derivatives: synthesis, bioactivity, molecular docking, and ADME-Tox studies. J Iran Chem Soc 19(2):563\u2013577","journal-title":"J Iran Chem Soc"},{"issue":"25","key":"847_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202301158","volume":"8","author":"FS Tokal\u0131","year":"2023","unstructured":"Tokal\u0131 FS, Taslimi P, Sadeghi M, \u015eenol H (2023) Synthesis and evaluation of quinazolin-4 (3H)-one derivatives as multitarget metabolic enzyme inhibitors: a biochemistry-oriented drug design. ChemistrySelect 8(25):e202301158","journal-title":"ChemistrySelect"},{"key":"847_CR40","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ejmech.2016.09.067","volume":"125","author":"G Wang","year":"2017","unstructured":"Wang G, Peng Z, Wang J, Li X, Li J (2017) Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential \u03b1-glucosidase inhibitors. Eur J Med Chem 125:423\u2013429","journal-title":"Eur J Med Chem"}],"updated-by":[{"DOI":"10.1007\/s10822-026-00968-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:00:00Z","timestamp":1793923200000}}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00847-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-026-00847-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00847-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T04:20:43Z","timestamp":1793938843000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-026-00847-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["847"],"URL":"https:\/\/doi.org\/10.1007\/s10822-026-00847-w","relation":{},"ISSN":["1573-4951"],"issn-type":[{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"18 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10822-026-00968-2","URL":"https:\/\/doi.org\/10.1007\/s10822-026-00968-2","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"144"}}